MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Single-photon emission computed tomography(SPECT)"

  • 2017 International Congress

    Assessment of cognitive impairment using FP-CIT SPECT

    N. Egawa, A. Kokuryu, Y. Inoue, A. Kuzuya, R. Takahashi (Kyoto, Japan)

    Objective: We aimed to assess the cognitive impairment using FP-CIT SPECT in mild cognitive impairment or dementia patients. Background: In general, FP-CIT SPECT reflect pre-synaptic dopamine…
  • 2017 International Congress

    Patterns of Striatal DAT Binding Loss in a Progressing Parkinson Disease (PD) Cohort: Four year PPMI Follow-up

    J. Seibyl, K. Marek (New Haven, CT, USA)

    Objective: To evaluate within subject striatal changes in dopamine transporter (DAT) binding using 123-I Ioflupane SPECT in PD participants studied over four years in the…
  • 2017 International Congress

    Combination of multimodal neuroimaging techniques is useful to diagnose multiple system atrophy

    K. Abe, K. Fukushima, k. Ando, Y. Maeda, N. Kotoura, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)

    Objective: To determine whether multiple system atrophy (MSA) patients can be differentiated form Parkinson's disease (PD) patients using combination of multimodal neuroimaging techniques. Background: MSA…
  • 2017 International Congress

    The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report

    A. Tran, M. Amin, R. Burns (Phoenix, AZ, USA)

    Objective: The role of MRI and DAT scan in Vascular Parkinsonism: A Case Report Background: DaTscan has become a widely used clinical tool to help clinicians…
  • 2017 International Congress

    Improved diagnosis of dementia with Lewy bodies by the combination of Tc-99m ECD SPECT with eZIS analysis and quantitative TRODAT-1 SPECT images

    C.-Y. Wei, P.-Y. Chiu (Changhua County, Taiwan)

    Objective: The development of easily useful neuroimaging may resolve to the delays of diagnosis. Background: Dementia with Lewy bodies (DLB) is easy to be misdiagnosed…
  • 2017 International Congress

    Voxel-based Analysis of Cholinesterase Inhibitor Response in Lewy Body Disorders: A Prospective Observational Study

    J. Compagnone, H. Mustaerts, J. Li, M. Freedman, K. Galit, J. Lee, J. Kennedy, R. Chen, D. Tang-Wai, A. Lang, N. Herrmann, S. Black, M. Masellis (Toronto, ON, Canada)

    Objective: The objective is to investigate functional neuroimaging correlates of response to ChEIs in LBD. Background: Lewy body disorders (LBD), including dementia with Lewy bodies…
  • 2017 International Congress

    Normal “heart” in Parkinson’s disease: Is this a distinct clinical phenotype?

    J.E. Lee, J.-S. Kim, Y.-S. Oh, D.-W. Ryu, I.-U. Song, K.-S. Lee (Seoul, Republic of Korea)

    Objective: The aim of this study was to investigate whether non-motor manifestations of Parkinson’s disease (PD) differ between patients with normal and abnormal myocardial metaiodobenzylguanidine (MIBG)…
  • 2017 International Congress

    DaTscan in clinical evaluation of Multiple System Atrophy

    P. Khemani, S. Vernino (Dallas, TX, USA)

    Objective: To explore accuracy of DaTscanTM Ioflupane I123 Injection (DaTscan) in a multiple system atrophy (MSA) cohort  Background: There are isolated cases of normal DaTscan in neuropathologically confirmed MSA-cerebellar subtype (MSA-C)…
  • 2017 International Congress

    Neuroimaging studies in familial forms of Parkinson’s disease: A systematic review

    J. Fernandez Bonfante, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aim to systematically review the current status of MRI, PET and SPECT imaging in asymptomatic (aPD) and symptomatic (sPD) genetic carriers of PD.…
  • 2017 International Congress

    Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging

    J. Infante, M. Sierra, I. Martínez-Rodríguez, P. Sánchjez-Juan, I. González-Aramburu, M. Jimenez-Alonso, A. Sánchez-Rodriguez, I. Banzo (Santander, Spain)

    Objective: To assess whether any of the biomarkers studied (UPDRS-III, SN echogenicity, UPSIT and DaT-SPECT) in a baseline evaluation of a cohort of LRRK2 G2019S asymptomatic…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Clinical Associations of Hand Deformities in Parkinson´s Disease
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley